文献速递细菌感染、耐药与抗菌药物医院感染防控

ICU普遍莫匹罗星去定植对MRSA PCR鼻拭子检测效用的影响评估

Evaluation of the Impact of Universal Mupirocin Decolonization in Intensive Care Units on the Utility of Methicillin-Resistant Staphylococcus aureus Polymerase Chain Reaction Nasal Swab Testing.
PubMed 文献 · Clin Infect Dis · 2026-01-01

本研究为回顾性队列研究,纳入2023年2月至2024年8月入住ICU并同时接受MRSA PCR鼻拭子检测和普遍莫匹罗星去定植的成人住院患者,按PCR检测时机分为去定植前、首剂后≤7天和>7天三组,主要结局为MRSA PCR鼻拭子的阴性预测值(NPV)。结果显示去定植后检测的NPV与去定植前相比差异分别为0.3%和-0.4%,结论认为莫匹罗星去定植后MRSA PCR鼻拭子的NPV并未降低,去定植开始后7天内检测非劣于去定植前检测。

要点

  • 莫匹罗星去定植后MRSA PCR鼻拭子NPV未降低。
  • 去定植开始后7天内检测非劣于去定植前检测。
  • ICU普遍去定植背景下仍可依赖MRSA PCR鼻拭子。

核心结论

  • 莫匹罗星去定植后MRSA PCR鼻拭子的阴性预测值未减弱。
  • 去定植开始后7天内行MRSA PCR检测非劣于去定植前检测。

研究设计与样本

  • 回顾性队列研究,纳入2023年2月至2024年8月入住ICU的成人住院患者,均接受MRSA PCR鼻拭子检测和普遍莫匹罗星去定植。
  • 按PCR检测时机分为三组:去定植前、首剂后>0至≤7天、首剂后>7天。
  • 主要分析共纳入1034例患者。

主要发现

  • 508例(49.1%)在去定植开始前采集MRSA PCR鼻拭子。
  • 388例(73.8%)在去定植开始后>0至≤7天采集鼻拭子,138例(26.2%)在>7天采集。
  • 去定植前与去定植后>7天组NPV差异为-0.4%(单侧95%CI -2.3%)。

临床怎么用

  • 在实施普遍莫匹罗星去定植的ICU中,MRSA PCR鼻拭子检测仍可用于阴性排除。
  • 去定植开始后7天内进行MRSA PCR鼻拭子检测,其阴性预测价值不劣于去定植前检测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The reliability of methicillin-resistant Staphylococcus aureus (MRSA) polymerase chain reaction (PCR) nasal swab testing in the context of mupirocin nasal decolonization has been questioned. This study investigated whether the negative predictive value (NPV) of MRSA PCR nasal swab testing following mupirocin decolonization was noninferior to testing prior to decolonization. METHODS: This retrospective cohort study included adult inpatients admitted to intensive care units (ICUs) from February 2023 to August 2024 who underwent both MRSA PCR nasal swab testing and universal mupirocin decolonization. Patients were divided into 3 groups based on timing of PCR testing: prior to receiving any doses of topical mupirocin, no more than 7 days after, or >7 days after a first dose. The primary outcome was the NPV of MRSA PCR nasal swab testing. RESULTS: A total of 1034 patients were included in the primary analysis; 508 (49.1%) had a MRSA PCR nasal swab collected prior to the start of decolonization and 388 (73.8%) and 138 (26.2%) received nasal swabs > 0 to ≤7 days and >7 days after the start of mupirocin decolonization, respectively. The differences between the NPV of MRSA PCR testing in patients with swabs collected prior versus in patients with swabs collected >0 to ≤7 days and >7 days after the start of mupirocin were 0.3% and -0.4% (1-sided 95% CI -.9% and CI -2.3%), respectively. CONCLUSIONS: The NPV of MRSA PCR nasal swabs is not diminished after mupirocin decolonization. MRSA PCR testing within 7 days of initiation of decolonization is noninferior to testing prior to decolonization.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Ito AS, Reasoner KC, Ong'uti SK, et al. Evaluation of the Impact of Universal Mupirocin Decolonization in Intensive Care Units on the Utility of Methicillin-Resistant Staphylococcus aureus Polymerase Chain Reaction Nasal Swab Testing. Clin Infect Dis. 2026. PMID: 41834148. doi:10.1093/cid/ciag183

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。